Dr. Robert L. Macdonald
VICC residency program receives ACGME approval
Vanderbilt-Ingram Cancer Center’s Radiation Oncology Residency program has become the first such program in the past decade to receive approval from the Accreditation Council for Graduate Medical Education.
The accreditation of the program will help address a significant shortage of specialists in this field in the southeastern United States, particularly among academic programs, said Dr. Dennis Hallahan, professor and chair of Radiation Oncology and residency director.
“The Mid-South is severely underrepresented, with no other Radiation Oncology residencies in Tennessee and none in Louisiana, Arkansas and Mississippi,” Hallahan said.
The residency will provide three years of clinical training with a fourth year in research training. Residents may choose from one of four categories for their research focus: clinical trials, cancer biology, bioengineering or applied physics.
Three residents will begin training on July 1, with three more the following year.